Analogous to treatment with TNFα, a control NF-κB agonist, reovirus infection resulted in equivalent (∼2- to 3-fold) activation of NF-κB-driven gene expression in wild-type and Bid-deficient cells (Figure 3A). This evidence concerns the gene BID and Reoviridae infectious disease.